期刊文献+

高危型人类乳头瘤病毒检测对意义不明确的非典型鳞状上皮细胞分层管理的临床价值 被引量:5

Evaluation of high-risk human papillomavirus testing in hierarchical management of patients with atypical squamous cells of undetermined significance
下载PDF
导出
摘要 目的评价高危型人类乳头瘤检测对意义不明确的非典型鳞状上皮细胞(ASCUS)分层管理的临床价值。方法对518例宫颈细胞学检查结果为ASCUS的患者进行高危型HPV检测和阴道镜检查,镜下定位活检可疑病灶,以病理学诊断作为金标准。结果 518例ASCUS患者中,高危型HPV阳性者为328例,其阳性率为63.32%。经病理学确诊高危型HPV阳性者CIN的发生率为50.19%,宫颈浸润癌的发生率为2.51%;高危型HPV阴性者CIN的发生率为2.90%,无宫颈浸润癌发生,两组比较差异有统计学意义(P<0.05)。ASCUS患者中阴道镜检查对CINⅡ、Ⅲ级检测的灵敏度、阴性预测值分别为78.84%、88.70%;高危型HPV检测对CINⅡ、Ⅲ级检测的灵敏度、阴性预测值分别为97.00%、96.84%。结论 ASCUS患者中高危型HPV阳性者宫颈病变的检出率较高,同时高危型HPV对CINⅡ、Ⅲ级检测的阴性预测值高,ASCUS患者的分层管理中高危型HPV检测起着重要的作用。 Objective To evaluation of high-risk human papillomavirus(HPV) testing in hierarchical management of women with atypical squamous cells of undetermined significance(ASCUS).Methods High-risk HPV testing was performed reflexively on 518 cases liquid-based Papanicolaou smears that had been interpreted as ASCUS.Final diagnosis were made by biopsy under the colposcopy.Results Of the 518 cases with cytological ASCUS,328(63.32%) cases were positive by high-risk HPV testing.In high-risk HPV positive patients,incidence of CIN was 50.19% and invasive cervical carcinom was 2.51%;high-risk HPV negative patients were 2.90%,and no invasive cervical carcinoma,the difference was statistically significant(P0.05).The sensitivity of colposcopy detecting CINⅡ and CINⅢ was 78.84%,and negative predictive value was 88.70%,the sensitivity of high-risk HPV was 97%,and negative predictive value was 96.84% in women with ASCUS.Conclusion High-risk HPV positive patients with ASCUS have higher detection rate of cervical lesions.High-risk types HPV has high negative predictive value for identification of CINⅡ and CINⅢ in women with ASCUS.The application of HPV DNA testing plays an important role in hierarchical management of patients with ASCUS.
出处 《安徽医科大学学报》 CAS 北大核心 2011年第8期801-804,共4页 Acta Universitatis Medicinalis Anhui
关键词 α乳头状瘤病毒属 宫颈肿瘤 阴道镜检查 alpha-papillomavirus uterine cervical neoplasms colposcopy
  • 相关文献

参考文献12

  • 1Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus type reflects viral evolution [ J ]. Virology, 2005,337 ( 1 ) :76 - 84.
  • 2Wright T C, Massad L S, Dunnton C J, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests [ J ]. AM J Obstet Gynecol,2007,197 (4) : 346 - 55.
  • 3Apgar B S,Zosehnick L,Wright T C Jr. The 2001 Bethesda system terminology[ J ]. Am Fam Physician ,2003,68 (10) : 1992 - 8.
  • 4ASCUS LSIL Triage Study (ALTS) Group. Results of a random- ized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance [ J]. Obstet Gynecol, 2003,188 (6) : 1383 - 92.
  • 5丘瑾,成佳景,吴逸,钱春妹,王光花,秦锦龙,童晓文.宫颈细胞学检查为ASCUS的临床意义及处理探讨[J].现代妇产科进展,2008,17(2):85-87. 被引量:42
  • 6Wright J D, Rader J S, Davila R, et al. Human papillomavirus tri- age for young women with atypical squamous cells of undetermined significance[J]. Obstet Gyneco1,2006,107 (4) :822 - 9.
  • 7Tarkkanen J, Auvinen E, Nieminen P, et al. HPV DNA testing as an adjunct in the management of patients with low grade cytologi- cal lesions in Finiand [ J ]. Aeta Obstet Gyneeol Stand, 2007,86 (3) :367 -72.
  • 8Tsai H J, Wu C H, Lai h 1, et al. Association between quantitative high-risk human papillomavirus DNA load and cervical intraepi- thelial neoplasm risk [ J ]. Cancer Epidemiol Biomarkers Prey, 2005,14( 11 ) :2544 -9.
  • 9Kiatpongsan S, Niruthisard S, Mutirangura A, et al. Role of human papillomavirus DNA testing in management of women with atypicalsquamous cells of undetermined significance [ J ]. lnt J Gynecol Cancer,2006,6 ( 1 ) :262 - 5.
  • 10Cox J T. History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results[ J]. Clin Viro1,2009,45 ( 1 ) : S1 - 12.

二级参考文献8

  • 1王建捷,靳家玉,冯凌.Reid阴道镜评分在诊断宫颈病变中的应用价值[J].北京医学,2005,27(8):454-455. 被引量:12
  • 2Syrjanen S, Shabalova IP, Petrovichev N, et al. Human papillomavirus testing and conventional Pap smear cytology as optional screening tools of women at different risks for cervical cancer in countries of the former Soviet Union [ J ]. J Low Genit Tract Dis,2002,6:97-110.
  • 3Montz FJ, Monk BJ, Fowler JM, et al. Natural history of the minimally abnormal Papanicolaou smear [ J ]. Obstet Gynecol, 1992,80:385-388.
  • 4Kinney WK, Manos MM, Hurley LB, et al. Where 's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnosis [ J ]. Obstet Gynecol, 1998,91:973-976.
  • 5Reid R, Scalzi P. Genital warts and cervical cancer Ⅶ. An improved colposcopic index for differentiating benign papillomaviral infections from high-grade cervical intraepithelial neoplasia[ J]. Am J Obstet Gynecol, 1985,153:611- 618.
  • 6Munoz N. Human papillomavirus and cancer:the epidemiological evidence [ J ]. J Clin Virol, 2000,19,1-5.
  • 7Solomon D, Schiffman M, Tarone R, et al. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance:baseline resuits from a randomized trial [ J ]. J Natl Cancer Inst, 2001,93:293-299.
  • 8Kulasingam SL, Kim JJ, Lawrence WF, et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS) [ J ]. J Nail Cancer Inst,2006,98:92-100.

共引文献41

同被引文献41

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部